Bottom line
What is EPASX's expense ratio?
EPASX's expense ratio is 1.77%, or about $177 a year on every $10,000 invested. That is more expensive than 90% of emerging markets funds we track (median 1.02%). This share class also charges a front-end sales load of up to 4.5%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Mar 4, 2026
EPASX fee table
| Net expense ratio | 1.77% |
|---|---|
| Gross expense ratio | 1.86% |
| Management fee | 1.08% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.51% |
| Acquired fund fees | 0.02% |
| Fee waiver / reimbursement | -0.09% |
| Max front-end sales load | 4.5% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Mar 4, 2026
What EPASX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| EPASX | $622 | $1,000 | $1,403 | $2,525 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.77% expense ratio costs roughly $91,700 in lost growth, versus about $56,400 for the median emerging markets fund (1.02%).